Medicine

Melissa Krebs Shares GelSana’s Vision for Innovative Wound Care Solutions

admin September 11, 2024

In this interview, Melissa Krebs, CEO and founder of GelSana, shares her journey in developing cutting-edge biomaterials that could transform the $78 billion wound care market.

LEAVE A RESPONSE Cancel reply

admin

View all posts

Medicine

Pfizer Makes Publicis New Global Creative Duties Partner

admin March 30, 2024

Medicine

Pusan National University Announces Potential Breakthrough for Muscle Regeneration Using Nanotech

admin January 20, 2024

Medicine

FDA Approves Rybrevant for Locally Advanced, Metastatic Epidermal Growth Factor Receptor Mutated Non-Small Cell Lung Cancer

admin September 21, 2024

Medicine

Johnson & Johnson Acquires Numab’s Investigational Antibody for the Treatment of Atopic Dermatitis

admin May 29, 2024

Kwarlay.com

Kwarlay.com

Melissa Krebs Shares GelSana’s Vision for Innovative Wound Care Solutions

LEAVE A RESPONSE Cancel reply

admin

Pfizer Makes Publicis New Global Creative Duties Partner

Pusan National University Announces Potential Breakthrough for Muscle Regeneration Using Nanotech

FDA Approves Rybrevant for Locally Advanced, Metastatic Epidermal Growth Factor Receptor Mutated Non-Small Cell Lung Cancer

Johnson & Johnson Acquires Numab’s Investigational Antibody for the Treatment of Atopic Dermatitis

Recent Posts

Archives

Categories

Melissa Krebs Shares GelSana’s Vision for Innovative Wound Care Solutions

LEAVE A RESPONSE Cancel reply

admin

You Might Also Like

Pfizer Makes Publicis New Global Creative Duties Partner

Pusan National University Announces Potential Breakthrough for Muscle Regeneration Using Nanotech

FDA Approves Rybrevant for Locally Advanced, Metastatic Epidermal Growth Factor Receptor Mutated Non-Small Cell Lung Cancer

Johnson & Johnson Acquires Numab’s Investigational Antibody for the Treatment of Atopic Dermatitis

Recent Posts

Archives

Categories